Filip Fremund
About Filip Fremund
Filip Fremund is the Senior Manager of Clinical Operations Czech Republic at Bristol Myers Squibb, with extensive experience in medical affairs and clinical operations at major pharmaceutical companies.
Company
Filip Fremund currently works at Bristol Myers Squibb, a global biopharmaceutical company. He holds the position of Senior Manager, Clinical Operations for the Czech Republic, specifically based in Hlavní město Praha. Bristol Myers Squibb is known for its commitment to discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases.
Title
Filip Fremund serves as the Senior Manager, Clinical Operations Czech Republic at Bristol Myers Squibb. In this role, he oversees clinical operations in the region, ensuring that clinical trials and other medical research activities align with regulatory standards and company directives.
Education and Expertise
Filip Fremund has an extensive academic background. He earned his Doktor všeobecné medicíny (MUDr.) degree in General Medicine from Charles University in 1993. He later achieved a Bakalář (Bc.) and Magistr (Mgr.) degree in Law from Paneurópska vysoká škola. He also holds an LL.M. in medical law, bioethics, data protection, and modern healthcare technologies from the Academy of Health Care Management. His education underscores his expertise in both medical and legal fields.
Background
Filip Fremund has a significant professional background in medical affairs and clinical operations. Prior to his current role, he worked as a Senior Scientific Advisor and Associate Medical Director Hematology & Oncology at Bristol Myers Squibb. He also held similar roles at Celgene, focusing on hematology & oncology for the Czech Republic & Slovakia. His career began at Roche, where he spent 12 years as a Group Medical Manager, enriching his experience in the pharmaceutical industry.
Achievements
Filip Fremund has transitioned through various significant roles in his career. Notably, he served as Associate Medical Director Hematology & Oncology and HCC Lead at both Celgene and Bristol Myers Squibb. His legal expertise in medical law and bioethics complements his extensive experience in clinical operations and medical affairs. Most recently, he transitioned to the role of Senior Manager, Clinical Operations Czech Republic at Bristol Myers Squibb in June 2023.